06160.HK
BeOne Medicines AG
HKSE · Healthcare · Biotechnology · CH
HKD 220.80
+1.19%Margins
Gross margin
87.8%
EBITDA margin
18.0%
EBIT margin
15.1%
Net margin
10.7%
FCF margin
21.4%
12.7%
Return on equity
7.1%
Return on assets
14.6%
Return on invested capital
0.69x
Asset turnover
HKD 11.7B
Cash from operations
HKD 28
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026